Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Dtsch Med Wochenschr ; 149(3): 93-100, 2024 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-38262403

RESUMO

Phosphate is essential for bone metabolism and for energy provision. Phosphate homeostasis is achieved by hormonal feedback mechanisms, predominantly parathyroid hormone, fibroblast growth factor 23 and calcitriol, with renal phosphate absorption taking on a special role. Although even large deviations from the serum normal range are rarely symptomatic, the health consequences can be significant. Essentially, the clinically relevant disturbances in phosphate balance can be attributed to three mechanisms: 1. shifts of phosphate between the extracellular space and the cytosol; 2. inadequate phosphate reabsorption in the kidney; 3. decreased intestinal phosphate absorption. Knowledge of physiology enables diagnosis and therapy of phosphate disorders.


Assuntos
Medicina Interna , Fosfatos , Humanos , Rim , Hormônio Paratireóideo
2.
N Engl J Med ; 387(25): 2356-2361, 2022 12 22.
Artigo em Inglês | MEDLINE | ID: mdl-36546627

RESUMO

A 27-year-old patient with a history of severe obstetrical complications and arterial thrombosis received a diagnosis of hereditary thrombotic thrombocytopenic purpura (TTP) due to severe ADAMTS13 deficiency when she presented with an acute episode in the 30th week of her second pregnancy. When the acute episode of hereditary TTP became plasma-refractory and fetal death was imminent, weekly injections of recombinant ADAMTS13 at a dose of 40 U per kilogram of body weight were initiated. The patient's platelet count normalized, and the growth of the fetus stabilized. At 37 weeks 1 day of gestation, a small-for-gestational-age boy was delivered by cesarean section. At the time of this report, the patient and her son were well, and she continued to receive injections of recombinant ADAMTS13 every 2 weeks. (Funded by the Swiss National Science Foundation.).


Assuntos
Complicações Hematológicas na Gravidez , Púrpura Trombocitopênica Trombótica , Adulto , Feminino , Humanos , Gravidez , Proteína ADAMTS13/administração & dosagem , Proteína ADAMTS13/deficiência , Proteína ADAMTS13/genética , Proteína ADAMTS13/uso terapêutico , Cesárea , Plasma , Contagem de Plaquetas , Púrpura Trombocitopênica Trombótica/diagnóstico , Púrpura Trombocitopênica Trombótica/genética , Púrpura Trombocitopênica Trombótica/terapia , Resultado da Gravidez , Complicações Hematológicas na Gravidez/genética , Complicações Hematológicas na Gravidez/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA